カテゴリー： Market Monitor Global, 世界, 医療/バイオ

消炎鎮痛解熱薬の世界市場見通し2023年-2029年

◆英語タイトル：Anti-Inflammatory Analgesic and Antipyretic Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5683）

◆商品コード：MMG23JU5683
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：128
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの消炎鎮痛解熱薬市場規模と予測を収録しています。・世界の消炎鎮痛解熱薬市場：売上、2018年-2023年、2024年-2029年
・世界の消炎鎮痛解熱薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の消炎鎮痛解熱薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「パラセタモール」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

消炎鎮痛解熱薬のグローバル主要企業は、Mallinckrodt Pharmaceuticals、 IOL、 Anqiu Lu'an Pharmaceutical、 Novacyl、 BASF、 Anhui BBCA Pharmaceuticals、 Hubei Biocause、 Xinhua Pharm、 Granules India Limited、 Huagang Pharm、 Hebei Jiheng Pharmaceutical、 Zhejiang Kangle Pharmaceutical、 Hebei Jingye Medical Technology、 MSPF、 Lu'an Pharmaceutical、 Mallinckrodt、 Farmson、 Anhui Fubore、 SKPL、 Atabay、 Huzhou Konch Pharmaceutical、 Anhui Topsun、 SOLARA、 SI Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、消炎鎮痛解熱薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の消炎鎮痛解熱薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の消炎鎮痛解熱薬市場：タイプ別市場シェア、2022年
・パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他

世界の消炎鎮痛解熱薬市場：用途別、2018年-2023年、2024年-2029年
世界の消炎鎮痛解熱薬市場：用途別市場シェア、2022年
・大人、子供

世界の消炎鎮痛解熱薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の消炎鎮痛解熱薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における消炎鎮痛解熱薬のグローバル売上、2018年-2023年
・主要企業における消炎鎮痛解熱薬のグローバル売上シェア、2022年
・主要企業における消炎鎮痛解熱薬のグローバル販売量、2018年-2023年
・主要企業における消炎鎮痛解熱薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Mallinckrodt Pharmaceuticals、 IOL、 Anqiu Lu'an Pharmaceutical、 Novacyl、 BASF、 Anhui BBCA Pharmaceuticals、 Hubei Biocause、 Xinhua Pharm、 Granules India Limited、 Huagang Pharm、 Hebei Jiheng Pharmaceutical、 Zhejiang Kangle Pharmaceutical、 Hebei Jingye Medical Technology、 MSPF、 Lu'an Pharmaceutical、 Mallinckrodt、 Farmson、 Anhui Fubore、 SKPL、 Atabay、 Huzhou Konch Pharmaceutical、 Anhui Topsun、 SOLARA、 SI Group

*************************************************************

・調査・分析レポートの概要
消炎鎮痛解熱薬市場の定義
市場セグメント
世界の消炎鎮痛解熱薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の消炎鎮痛解熱薬市場規模
世界の消炎鎮痛解熱薬市場規模：2022年 VS 2029年
世界の消炎鎮痛解熱薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの消炎鎮痛解熱薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の消炎鎮痛解熱薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：パラセタモール、アスピリン、イブプロフェン、ナプロキセン、ジクロフェナク、オキサプロジン、デキシブプロフェン、その他
消炎鎮痛解熱薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大人、子供
消炎鎮痛解熱薬の用途別グローバル売上・予測

・地域別市場分析
地域別消炎鎮痛解熱薬市場規模 2022年と2029年
地域別消炎鎮痛解熱薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Mallinckrodt Pharmaceuticals、 IOL、 Anqiu Lu'an Pharmaceutical、 Novacyl、 BASF、 Anhui BBCA Pharmaceuticals、 Hubei Biocause、 Xinhua Pharm、 Granules India Limited、 Huagang Pharm、 Hebei Jiheng Pharmaceutical、 Zhejiang Kangle Pharmaceutical、 Hebei Jingye Medical Technology、 MSPF、 Lu'an Pharmaceutical、 Mallinckrodt、 Farmson、 Anhui Fubore、 SKPL、 Atabay、 Huzhou Konch Pharmaceutical、 Anhui Topsun、 SOLARA、 SI Group
...

Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
This report aims to provide a comprehensive presentation of the global market for Anti-Inflammatory Analgesic and Antipyretic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Inflammatory Analgesic and Antipyretic Drugs. This report contains market size and forecasts of Anti-Inflammatory Analgesic and Antipyretic Drugs in global, including the following market information:
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Anti-Inflammatory Analgesic and Antipyretic Drugs companies in 2022 (%)
The global Anti-Inflammatory Analgesic and Antipyretic Drugs market was valued at US$ 2789.5 million in 2022 and is projected to reach US$ 3123.1 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Shandong Xinhua Pharmaceutical Company Limited and Mallinckrodt Pharmaceuticals are the top 2 manufacturers of antipyretic and analgesic raw materials globally and holds over 30% of global market share in total. Geographically speaking, North America holds about 25% of total market share, followed by China with over 20% share. In terms of type, paracetamol segment holds over half of total market share, followed by ibuprofen with over 20% share. In terms of end users, adult segment holds a dominant share of over 70%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, by Type, 2022 (%)
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs revenues share in global market, 2022 (%)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Anti-Inflammatory Analgesic and Antipyretic Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu’an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu’an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Inflammatory Analgesic and Antipyretic Drugs, market overview.
Chapter 2: Global Anti-Inflammatory Analgesic and Antipyretic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Inflammatory Analgesic and Antipyretic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-Inflammatory Analgesic and Antipyretic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Overall Market Size
2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-Inflammatory Analgesic and Antipyretic Drugs Players in Global Market
3.2 Top Global Anti-Inflammatory Analgesic and Antipyretic Drugs Companies Ranked by Revenue
3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Companies
3.4 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Companies
3.5 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Inflammatory Analgesic and Antipyretic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Markets, 2022 & 2029
4.1.2 Paracetamol
4.1.3 Aspirin
4.1.4 Ibuprofen
4.1.5 Naproxen
4.1.6 Diclofenac
4.1.7 Oxaprozin
4.1.8 Dexibuprofen
4.1.9 Others
4.2 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue & Forecasts
4.2.1 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2023
4.2.2 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2024-2029
4.2.3 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales & Forecasts
4.3.1 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2023
4.3.2 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2024-2029
4.3.3 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue & Forecasts
5.2.1 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2023
5.2.2 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2024-2029
5.2.3 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales & Forecasts
5.3.1 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2023
5.3.2 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2024-2029
5.3.3 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2022 & 2029
6.2 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue & Forecasts
6.2.1 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2023
6.2.2 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2024-2029
6.2.3 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales & Forecasts
6.3.1 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2023
6.3.2 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2024-2029
6.3.3 By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2029
6.4.2 By Country – North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2029
6.4.3 US Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.4.4 Canada Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2029
6.5.3 Germany Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5.4 France Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5.6 Italy Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5.7 Russia Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2029
6.6.3 China Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.6.4 Japan Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.6.7 India Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2029
6.7.2 By Country – South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2029
6.7.3 Brazil Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, 2018-2029
6.8.3 Turkey Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.8.4 Israel Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
6.8.6 UAE Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Company Summary
7.1.2 Mallinckrodt Pharmaceuticals Business Overview
7.1.3 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.1.4 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Mallinckrodt Pharmaceuticals Key News & Latest Developments
7.2 IOL
7.2.1 IOL Company Summary
7.2.2 IOL Business Overview
7.2.3 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.2.4 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.2.5 IOL Key News & Latest Developments
7.3 Anqiu Lu’an Pharmaceutical
7.3.1 Anqiu Lu’an Pharmaceutical Company Summary
7.3.2 Anqiu Lu’an Pharmaceutical Business Overview
7.3.3 Anqiu Lu’an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.3.4 Anqiu Lu’an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Anqiu Lu’an Pharmaceutical Key News & Latest Developments
7.4 Novacyl
7.4.1 Novacyl Company Summary
7.4.2 Novacyl Business Overview
7.4.3 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.4.4 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novacyl Key News & Latest Developments
7.5 BASF
7.5.1 BASF Company Summary
7.5.2 BASF Business Overview
7.5.3 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.5.4 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.5.5 BASF Key News & Latest Developments
7.6 Anhui BBCA Pharmaceuticals
7.6.1 Anhui BBCA Pharmaceuticals Company Summary
7.6.2 Anhui BBCA Pharmaceuticals Business Overview
7.6.3 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.6.4 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Anhui BBCA Pharmaceuticals Key News & Latest Developments
7.7 Hubei Biocause
7.7.1 Hubei Biocause Company Summary
7.7.2 Hubei Biocause Business Overview
7.7.3 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.7.4 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Hubei Biocause Key News & Latest Developments
7.8 Xinhua Pharm
7.8.1 Xinhua Pharm Company Summary
7.8.2 Xinhua Pharm Business Overview
7.8.3 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.8.4 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Xinhua Pharm Key News & Latest Developments
7.9 Granules India Limited
7.9.1 Granules India Limited Company Summary
7.9.2 Granules India Limited Business Overview
7.9.3 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.9.4 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Granules India Limited Key News & Latest Developments
7.10 Huagang Pharm
7.10.1 Huagang Pharm Company Summary
7.10.2 Huagang Pharm Business Overview
7.10.3 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.10.4 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Huagang Pharm Key News & Latest Developments
7.11 Hebei Jiheng Pharmaceutical
7.11.1 Hebei Jiheng Pharmaceutical Company Summary
7.11.2 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Business Overview
7.11.3 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.11.4 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Hebei Jiheng Pharmaceutical Key News & Latest Developments
7.12 Zhejiang Kangle Pharmaceutical
7.12.1 Zhejiang Kangle Pharmaceutical Company Summary
7.12.2 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Business Overview
7.12.3 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.12.4 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Zhejiang Kangle Pharmaceutical Key News & Latest Developments
7.13 Hebei Jingye Medical Technology
7.13.1 Hebei Jingye Medical Technology Company Summary
7.13.2 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Business Overview
7.13.3 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.13.4 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Hebei Jingye Medical Technology Key News & Latest Developments
7.14 MSPF
7.14.1 MSPF Company Summary
7.14.2 MSPF Business Overview
7.14.3 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.14.4 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.14.5 MSPF Key News & Latest Developments
7.15 Lu’an Pharmaceutical
7.15.1 Lu’an Pharmaceutical Company Summary
7.15.2 Lu’an Pharmaceutical Business Overview
7.15.3 Lu’an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.15.4 Lu’an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Lu’an Pharmaceutical Key News & Latest Developments
7.16 Mallinckrodt
7.16.1 Mallinckrodt Company Summary
7.16.2 Mallinckrodt Business Overview
7.16.3 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.16.4 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Mallinckrodt Key News & Latest Developments
7.17 Farmson
7.17.1 Farmson Company Summary
7.17.2 Farmson Business Overview
7.17.3 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.17.4 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.17.5 Farmson Key News & Latest Developments
7.18 Anhui Fubore
7.18.1 Anhui Fubore Company Summary
7.18.2 Anhui Fubore Business Overview
7.18.3 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.18.4 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.18.5 Anhui Fubore Key News & Latest Developments
7.19 SKPL
7.19.1 SKPL Company Summary
7.19.2 SKPL Business Overview
7.19.3 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.19.4 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.19.5 SKPL Key News & Latest Developments
7.20 Atabay
7.20.1 Atabay Company Summary
7.20.2 Atabay Business Overview
7.20.3 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.20.4 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Atabay Key News & Latest Developments
7.21 Huzhou Konch Pharmaceutical
7.21.1 Huzhou Konch Pharmaceutical Company Summary
7.21.2 Huzhou Konch Pharmaceutical Business Overview
7.21.3 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.21.4 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Huzhou Konch Pharmaceutical Key News & Latest Developments
7.22 Anhui Topsun
7.22.1 Anhui Topsun Company Summary
7.22.2 Anhui Topsun Business Overview
7.22.3 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.22.4 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.22.5 Anhui Topsun Key News & Latest Developments
7.23 SOLARA
7.23.1 SOLARA Company Summary
7.23.2 SOLARA Business Overview
7.23.3 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.23.4 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.23.5 SOLARA Key News & Latest Developments
7.24 SI Group
7.24.1 SI Group Company Summary
7.24.2 SI Group Business Overview
7.24.3 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Major Product Offerings
7.24.4 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales and Revenue in Global (2018-2023)
7.24.5 SI Group Key News & Latest Developments
8 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity, Analysis
8.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity, 2018-2029
8.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-Inflammatory Analgesic and Antipyretic Drugs Supply Chain Analysis
10.1 Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Value Chain
10.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Upstream Market
10.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anti-Inflammatory Analgesic and Antipyretic Drugs in Global Market
Table 2. Top Anti-Inflammatory Analgesic and Antipyretic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Companies, (Tons), 2018-2023
Table 6. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Product Type
Table 9. List of Global Tier 1 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Inflammatory Analgesic and Antipyretic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2018-2023
Table 15. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2024-2029
Table 16. By Application – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2018-2023
Table 20. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2024-2029
Table 21. By Region – Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2018-2023
Table 25. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), 2024-2029
Table 26. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 29. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2024-2029
Table 30. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 33. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2024-2029
Table 34. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 37. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2024-2029
Table 38. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 41. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, (Tons), 2024-2029
Table 46. Mallinckrodt Pharmaceuticals Company Summary
Table 47. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 48. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Mallinckrodt Pharmaceuticals Key News & Latest Developments
Table 50. IOL Company Summary
Table 51. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 52. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. IOL Key News & Latest Developments
Table 54. Anqiu Lu'an Pharmaceutical Company Summary
Table 55. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 56. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. Anqiu Lu'an Pharmaceutical Key News & Latest Developments
Table 58. Novacyl Company Summary
Table 59. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 60. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Novacyl Key News & Latest Developments
Table 62. BASF Company Summary
Table 63. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 64. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. BASF Key News & Latest Developments
Table 66. Anhui BBCA Pharmaceuticals Company Summary
Table 67. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 68. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Anhui BBCA Pharmaceuticals Key News & Latest Developments
Table 70. Hubei Biocause Company Summary
Table 71. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 72. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Hubei Biocause Key News & Latest Developments
Table 74. Xinhua Pharm Company Summary
Table 75. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 76. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Xinhua Pharm Key News & Latest Developments
Table 78. Granules India Limited Company Summary
Table 79. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 80. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 81. Granules India Limited Key News & Latest Developments
Table 82. Huagang Pharm Company Summary
Table 83. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 84. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 85. Huagang Pharm Key News & Latest Developments
Table 86. Hebei Jiheng Pharmaceutical Company Summary
Table 87. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 88. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 89. Hebei Jiheng Pharmaceutical Key News & Latest Developments
Table 90. Zhejiang Kangle Pharmaceutical Company Summary
Table 91. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 92. Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 93. Zhejiang Kangle Pharmaceutical Key News & Latest Developments
Table 94. Hebei Jingye Medical Technology Company Summary
Table 95. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 96. Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 97. Hebei Jingye Medical Technology Key News & Latest Developments
Table 98. MSPF Company Summary
Table 99. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 100. MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 101. MSPF Key News & Latest Developments
Table 102. Lu'an Pharmaceutical Company Summary
Table 103. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 104. Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 105. Lu'an Pharmaceutical Key News & Latest Developments
Table 106. Mallinckrodt Company Summary
Table 107. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 108. Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 109. Mallinckrodt Key News & Latest Developments
Table 110. Farmson Company Summary
Table 111. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 112. Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 113. Farmson Key News & Latest Developments
Table 114. Anhui Fubore Company Summary
Table 115. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 116. Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 117. Anhui Fubore Key News & Latest Developments
Table 118. SKPL Company Summary
Table 119. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 120. SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 121. SKPL Key News & Latest Developments
Table 122. Atabay Company Summary
Table 123. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 124. Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 125. Atabay Key News & Latest Developments
Table 126. Huzhou Konch Pharmaceutical Company Summary
Table 127. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 128. Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 129. Huzhou Konch Pharmaceutical Key News & Latest Developments
Table 130. Anhui Topsun Company Summary
Table 131. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 132. Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 133. Anhui Topsun Key News & Latest Developments
Table 134. SOLARA Company Summary
Table 135. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 136. SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 137. SOLARA Key News & Latest Developments
Table 138. SI Group Company Summary
Table 139. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offerings
Table 140. SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 141. SI Group Key News & Latest Developments
Table 142. Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 143. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 144. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production by Region, 2018-2023 (Tons)
Table 145. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production by Region, 2024-2029 (Tons)
Table 146. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Opportunities & Trends in Global Market
Table 147. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Drivers in Global Market
Table 148. Anti-Inflammatory Analgesic and Antipyretic Drugs Market Restraints in Global Market
Table 149. Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Materials
Table 150. Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Materials Suppliers in Global Market
Table 151. Typical Anti-Inflammatory Analgesic and Antipyretic Drugs Downstream
Table 152. Anti-Inflammatory Analgesic and Antipyretic Drugs Downstream Clients in Global Market
Table 153. Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Type in 2022
Figure 2. Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Application in 2022
Figure 3. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Inflammatory Analgesic and Antipyretic Drugs Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Anti-Inflammatory Analgesic and Antipyretic Drugs by Region, 2022 VS 2029
Figure 54. Anti-Inflammatory Analgesic and Antipyretic Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 消炎鎮痛解熱薬の世界市場見通し2023年-2029年(Anti-Inflammatory Analgesic and Antipyretic Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

消炎鎮痛解熱薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp